Collateral for a security interest recorded Apr 8, 2026 (Royal Bank of Canada).
Term ends May 30, 2029 · High confidence
20-year base term ends Dec 11, 2026
Held by Cytyc Corporation
Filed Dec 11, 2006 as application 11/609,274 · Granted Aug 3, 2010
Base term plus 901 days of patent term adjustment (USPTO delay)
Today
2006
2029
Clock starts
Dec 11, 2006
Dec 11, 2006
Term ends
May 30, 2029
May 30, 2029
Granted
Aug 3, 2010
Aug 3, 2010
base term
patent term adjustment
fee events
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
901
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
3
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 901 days past its 20-year base term on prosecution delay. All three maintenance fees are recorded paid; no more fees are due. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Dec 11, 2006, when this application, 11/609,274, was filed | Dec 11, 2026 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +901 days, USPTO patent term adjustment record | May 30, 2029 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | May 30, 2029 | High confidence |
This family
| US 7,769,219 | this patent May 2029 | May 2029 |
| Application PCT/US2007/085627 | PCT application no patent term | no patent term |
| US 8,014,583 | In force Dec 2026 | Dec 2026 |
The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Dec 11, 2006 Reel 18614, frame 132 | Zahniser, Michael | Cytyc Corporation | Assignment of Assignor's Interest |
| Oct 26, 2007 Reel 20018, frame 529 | Cytyc Corporation | Goldman Sachs Credit Partners L.P. | Patent Security Agreement |
| Jul 29, 2008 Reel 21301, frame 879 | Cytyc Corporation | Goldman Sachs Credit Partners L.P., as Collateral Agent | Patent Security Agreement |
| Aug 26, 2010 Reel 24892, frame 1 | Goldman Sachs Credit Partners, L.P., as Collateral Agent | Hologic, Inc.; R2 Technology, Inc.; Suros Surgical Systems, Inc.; Biolucent, LLC; Direct Radiography Corp.; Cytyc Surgical Products II Limited Partnership; Cytyc Surgical Products Limited Partnership; Cytyc Corporation; Cytyc Surgical Products III, Inc.; Cytyc Prenatal Products Corp.; Third Wave Technologies, Inc. | Termination of Patent Security Agreements and Release of Security Interests |
| Aug 26, 2010 reel/frame not recorded | Goldman Sachs Credit Partners, L.P., as Collateral Agent | Hologic, Inc. | Termination of Patent Security Agreements and Release of Security Interests |
| Aug 26, 2010 reel/frame not recorded | Goldman Sachs Credit Partners, L.P., as Collateral Agent | R2 Technology, Inc. | Termination of Patent Security Agreements and Release of Security Interests |
| Aug 26, 2010 reel/frame not recorded | Goldman Sachs Credit Partners, L.P., as Collateral Agent | Suros Surgical Systems, Inc. | Termination of Patent Security Agreements and Release of Security Interests |
| Aug 26, 2010 reel/frame not recorded | Goldman Sachs Credit Partners, L.P., as Collateral Agent | Biolucent, LLC | Termination of Patent Security Agreements and Release of Security Interests |
| Aug 26, 2010 reel/frame not recorded | Goldman Sachs Credit Partners, L.P., as Collateral Agent | Direct Radiography Corp. | Termination of Patent Security Agreements and Release of Security Interests |
| Aug 26, 2010 reel/frame not recorded | Goldman Sachs Credit Partners, L.P., as Collateral Agent | Cytyc Surgical Products II Limited Partnership | Termination of Patent Security Agreements and Release of Security Interests |
| Aug 26, 2010 reel/frame not recorded | Goldman Sachs Credit Partners, L.P., as Collateral Agent | Cytyc Surgical Products Limited Partnership | Termination of Patent Security Agreements and Release of Security Interests |
| Aug 26, 2010 reel/frame not recorded | Goldman Sachs Credit Partners, L.P., as Collateral Agent | Cytyc Corporation | Termination of Patent Security Agreements and Release of Security Interests |
| Aug 26, 2010 reel/frame not recorded | Goldman Sachs Credit Partners, L.P., as Collateral Agent | Cytyc Surgical Products III, Inc. | Termination of Patent Security Agreements and Release of Security Interests |
| Aug 26, 2010 reel/frame not recorded | Goldman Sachs Credit Partners, L.P., as Collateral Agent | Cytyc Prenatal Products Corp. | Termination of Patent Security Agreements and Release of Security Interests |
| Aug 26, 2010 reel/frame not recorded | Goldman Sachs Credit Partners, L.P., as Collateral Agent | Third Wave Technologies, Inc. | Termination of Patent Security Agreements and Release of Security Interests |
| Aug 1, 2012 Reel 28810, frame 745 | Hologic, Inc.; Biolucent, LLC; Cytyc Corporation; Cytyc Surgical Products, Limited Partnership; Suros Surgical Systems, Inc.; Third Wave Technologies, Inc.; Gen-Probe Incorporated | Goldman Sachs Bank USA | Security Agreement |
| Jun 4, 2015 Reel 35820, frame 239 | Goldman Sachs Bank USA, as Collateral Agent | Hologic, Inc.; Biolucent, LLC; Cytyc Corporation; Cytyc Surgical Products, Limited Partnership; Suros Surgical Systems, Inc.; Third Wave Technologies, Inc.; Gen-Probe Incorporated | Security Interest Release Reel/Frame 028810/0745 |
| Jun 4, 2015 reel/frame not recorded | Goldman Sachs Bank USA, as Collateral Agent | Hologic, Inc. | Security Interest Release Reel/Frame 028810/0745 |
| Jun 4, 2015 reel/frame not recorded | Goldman Sachs Bank USA, as Collateral Agent | Biolucent, LLC | Security Interest Release Reel/Frame 028810/0745 |
| Jun 4, 2015 reel/frame not recorded | Goldman Sachs Bank USA, as Collateral Agent | Cytyc Corporation | Security Interest Release Reel/Frame 028810/0745 |
| Jun 4, 2015 reel/frame not recorded | Goldman Sachs Bank USA, as Collateral Agent | Cytyc Surgical Products, Limited Partnership | Security Interest Release Reel/Frame 028810/0745 |
| Jun 4, 2015 reel/frame not recorded | Goldman Sachs Bank USA, as Collateral Agent | Suros Surgical Systems, Inc. | Security Interest Release Reel/Frame 028810/0745 |
| Jun 4, 2015 reel/frame not recorded | Goldman Sachs Bank USA, as Collateral Agent | Third Wave Technologies, Inc. | Security Interest Release Reel/Frame 028810/0745 |
| Jun 4, 2015 reel/frame not recorded | Goldman Sachs Bank USA, as Collateral Agent | Gen-Probe Incorporated | Security Interest Release Reel/Frame 028810/0745 |
| Aug 7, 2015 Reel 36307, frame 199 | Hologic, Inc.; Biolucent, LLC; Cytyc Corporation; Cytyc Surgical Products, Limited Partnership; Direct Radiography Corp.; Gen-Probe Incorporated; Gen-Probe Prodesse, Inc.; Suros Surgical Systems, Inc.; Third Wave Technologies, Inc. | Bank of America, N.A., as Collateral Agent | Security Agreement |
| Nov 9, 2017 Reel 44432, frame 565 | Hologic, Inc.; Biolucent, LLC; Cytyc Corporation; Cytyc Surgical Products, Limited Partnership; Suros Surgical Systems, Inc.; Third Wave Technologies, Inc.; Gen-Probe Incorporated | Goldman Sachs Bank USA | Corrective Assignment to Correct the Incorrect Patent No. 8081301 Previously Recorded at Reel: 028810 Frame: 0745. Assignor(S) Hereby Confirms the Security Agreement. |
| Nov 9, 2017 Reel 44727, frame 529 | Goldman Sachs Bank USA, as Collateral Agent | Hologic, Inc.; Biolucent, LLC; Cytyc Corporation; Cytyc Surgical Products, Limited Partnership; Suros Surgical Systems, Inc.; Third Wave Technologies, Inc.; Gen-Probe Incorporated | Corrective Assignment to Correct the Incorrect Patent No. 8081301 Previously Recorded at Reel: 035820 Frame: 0239. Assignor(S) Hereby Confirms the Security Interest Release. |
| Nov 9, 2017 reel/frame not recorded | Goldman Sachs Bank USA, as Collateral Agent | Hologic, Inc. | Corrective Assignment to Correct the Incorrect Patent No. 8081301 Previously Recorded at Reel: 035820 Frame: 0239. Assignor(S) Hereby Confirms the Security Interest Release. |
| Nov 9, 2017 reel/frame not recorded | Goldman Sachs Bank USA, as Collateral Agent | Biolucent, LLC | Corrective Assignment to Correct the Incorrect Patent No. 8081301 Previously Recorded at Reel: 035820 Frame: 0239. Assignor(S) Hereby Confirms the Security Interest Release. |
| Nov 9, 2017 reel/frame not recorded | Goldman Sachs Bank USA, as Collateral Agent | Cytyc Corporation | Corrective Assignment to Correct the Incorrect Patent No. 8081301 Previously Recorded at Reel: 035820 Frame: 0239. Assignor(S) Hereby Confirms the Security Interest Release. |
| Nov 9, 2017 reel/frame not recorded | Goldman Sachs Bank USA, as Collateral Agent | Cytyc Surgical Products, Limited Partnership | Corrective Assignment to Correct the Incorrect Patent No. 8081301 Previously Recorded at Reel: 035820 Frame: 0239. Assignor(S) Hereby Confirms the Security Interest Release. |
| Nov 9, 2017 reel/frame not recorded | Goldman Sachs Bank USA, as Collateral Agent | Suros Surgical Systems, Inc. | Corrective Assignment to Correct the Incorrect Patent No. 8081301 Previously Recorded at Reel: 035820 Frame: 0239. Assignor(S) Hereby Confirms the Security Interest Release. |
| Nov 9, 2017 reel/frame not recorded | Goldman Sachs Bank USA, as Collateral Agent | Third Wave Technologies, Inc. | Corrective Assignment to Correct the Incorrect Patent No. 8081301 Previously Recorded at Reel: 035820 Frame: 0239. Assignor(S) Hereby Confirms the Security Interest Release. |
| Nov 9, 2017 reel/frame not recorded | Goldman Sachs Bank USA, as Collateral Agent | Gen-Probe Incorporated | Corrective Assignment to Correct the Incorrect Patent No. 8081301 Previously Recorded at Reel: 035820 Frame: 0239. Assignor(S) Hereby Confirms the Security Interest Release. |
| Apr 8, 2026 Reel 75462, frame 440 | Biotheranostics, Inc.; Gen-Probe Incorporated; Gen-Probe Prodesse, Inc.; Cytyc Corporation; Suros Surgical Systems, Inc.; Gynesonics, Inc.; Bolder Surgical, LLC; Faxitron Bioptics, LLC; Health Beacons, Inc.; Hologic, Inc. | Royal Bank of Canada, as Collateral Agent | Security Interest |
| Apr 8, 2026 Reel 75926, frame 339 | Biotheranostics, Inc.; Gen-Probe Incorporated; Gen-Probe Prodesse, Inc.; Cytyc Corporation; Suros Surgical Systems, Inc.; Gynesonics, Inc.; Bolder Surgical, LLC; Faxitron Bioptics, LLC; Health Beacons, Inc.; Hologic, Inc. | Citibank, N.A., as Collateral Agent | Security Interest |
| Apr 28, 2026 Reel 75566, frame 39 | Bank of America, N.A., as Collateral Agent | Hologic, Inc., on Its Own Behalf and as Successor-by-Merger to Direct Radiography Corp.; Cytyc Corporation, on Its Own Behalf and as Successor-by-Merger to Biolucent, LLC; Cytyc Surgical Products, LLC, as Successor-by-Conversion to Cytyc Surgical Products, Limited Partnership; Gen-Probe Incorporated, on Its Own Behalf and as Successor-by-Merger to Third Wave Technologies, Inc.; Gen-Probe Prodesse, Inc.; Suros Surgical Systems, Inc. | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
May 2029
Term ends May 30, 2029. No further fees fall due before then
Note
The 901 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
98
later US patents cite this one
That is top 10% of utility patents granted in 2010 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.